Quadrant Capital Group LLC Precigen, Inc. Transaction History

Quadrant Capital Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$1.27 - $2.26 $1,619 - $2,881	1,275 Added 692.93%	1,459 $2,000
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $259 - $513	184 New	184 $0
Q1 2022 May 06, 2022	SELL	$1.91 - $3.98 $525 - $1,094	-275 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $378 - $955	175 Added 175.0%	275 $1,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $146 - $719	100 New	100 $0

144

160M

136K

4.8K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $371M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.